Apollo Endosurgery's operating income is $-28M.
Get informed when a big investor buys or sells
+ FollowAs of Dec 31, 2022
Trailing 12 months ending Dec 31, 2022
Apollo Endosurgery (APEN) currently reports a operating income of $-28M as of December 2022. That compares with $-20M in the prior-year period — down 41.4% year over year. Use the charts on this page to explore Apollo Endosurgery's operating income history and peer comparisons.
Apollo Endosurgery's operating income decreased from $-20M to $-28M — a 41.4% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Apollo Endosurgery reported $-28M in operating income as of December 2022. That compares with $-20M in the prior-year period — down 41.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current operating income of $-28M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Apollo Endosurgery, and consider following APEN for alerts when major investors trade the stock.
Apollo Endosurgery is classified in the Healthcare sector. On operating income, it currently shows $-28M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing APEN with unrelated industries.